CIG
AMGN icon

Cascade Investment Group’s Amgen AMGN Stock Holding History

Cascade Investment Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,063
Closed -$302K – 131
2024
Q1 		$302K Buy
1,063
+221
+26% +$64.7K 0.23% 103
2023
Q4 		$243K Buy
842
+17
+2% +$4.63K 0.2% 115
2023
Q3 		$222K Buy
+825
New +$206K 0.21% 106

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cascade Investment Group's AMGN Position: Q2 2024 in Review

Cascade Investment Group sold out of Amgen (AMGN) in Q2 2024, closing a stake of 1,063 shares — an estimated $302K sold.

Cascade Investment Group first reported a position in AMGN in Q3 2023 and held it in 3 quarters. The position peaked at $302K in Q1 2024. 2,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Cascade Investment Group reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • Cascade Investment Group sold 1,063 Amgen shares in Q2 2024, an estimated $302K.
  • Cascade Investment Group first reported a position in Amgen in Q3 2023 and held it in 3 quarters.
  • Cascade Investment Group's Amgen position peaked at $302K in Q1 2024.
  • 2,785 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Cascade Investment Group's 13F filing for Q2 2024, filed 16 Jul 2024.